Do analysts recommend OPTX or KEQU?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syntec Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer OPTX or KEQU?

In the previous week, Syntec Optics and Syntec Optics both had 2 articles in the media. Syntec Optics' average media sentiment score of 0.94 beat Kewaunee Scientific's score of 0.93 indicating that Syntec Optics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Syntec Optics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kewaunee Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend KEQU or LAB?

Standard BioTools has a consensus target price of $1.35, indicating a potential upside of 18.42%. Given Standard BioTools' higher possible upside, analysts plainly believe Standard BioTools is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Standard BioTools 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Do analysts recommend NAUT or KEQU?

Nautilus Biotechnology currently has a consensus target price of $4.00, indicating a potential upside of 55.04%. Given Nautilus Biotechnology's higher probable upside, analysts plainly believe Nautilus Biotechnology is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nautilus Biotechnology 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor NAUT or KEQU?

In the previous week, Nautilus Biotechnology and Nautilus Biotechnology both had 2 articles in the media. Nautilus Biotechnology's average media sentiment score of 0.94 beat Kewaunee Scientific's score of 0.93 indicating that Nautilus Biotechnology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nautilus Biotechnology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kewaunee Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend KEQU or PRE?

Prenetics Global has a consensus price target of $32.33, indicating a potential upside of 55.22%. Given Prenetics Global's stronger consensus rating and higher possible upside, analysts plainly believe Prenetics Global is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Prenetics Global 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Does the media refer more to KEQU or PRE?

In the previous week, Kewaunee Scientific and Kewaunee Scientific both had 2 articles in the media. Prenetics Global's average media sentiment score of 0.94 beat Kewaunee Scientific's score of 0.93 indicating that Prenetics Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kewaunee Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Prenetics Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer MASS or KEQU?

908 Devices presently has a consensus target price of $12.00, suggesting a potential upside of 38.57%. Given 908 Devices' higher possible upside, analysts plainly believe 908 Devices is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 908 Devices 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer MASS or KEQU?

In the previous week, 908 Devices had 6 more articles in the media than Kewaunee Scientific. MarketBeat recorded 8 mentions for 908 Devices and 2 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 0.93 beat 908 Devices' score of -0.03 indicating that Kewaunee Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 908 Devices 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Kewaunee Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Kewaunee Scientific (KEQU) Competitors

$39.56 -1.01 (-2.49%)

Closing price 04:00 PM Eastern

Extended Trading

$39.90 +0.34 (+0.85%)

As of 04:04 PM Eastern

Compare

KEQU vs. OPTX, LAB, NAUT, PRE, and MASS

Should you buy Kewaunee Scientific stock or one of its competitors? MarketBeat compares Kewaunee Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kewaunee Scientific include Syntec Optics (OPTX), Standard BioTools (LAB), Nautilus Biotechnology (NAUT), Prenetics Global (PRE), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.

How does Kewaunee Scientific compare to Syntec Optics?

Syntec Optics (NASDAQ:OPTX) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

Syntec Optics has a beta of -0.82, meaning that its stock price is 182% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market.

Kewaunee Scientific has a net margin of 3.85% compared to Syntec Optics' net margin of -10.95%. Kewaunee Scientific's return on equity of 18.09% beat Syntec Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syntec Optics	-10.95%	-30.86%	-12.35%
Kewaunee Scientific	3.85%	18.09%	6.71%

In the previous week, Syntec Optics and Syntec Optics both had 2 articles in the media. Syntec Optics' average media sentiment score of 0.94 beat Kewaunee Scientific's score of 0.93 indicating that Syntec Optics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Syntec Optics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kewaunee Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Kewaunee Scientific has higher revenue and earnings than Syntec Optics. Syntec Optics is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syntec Optics	$28.08M	18.12	-$1.79M	-$0.08	N/A
Kewaunee Scientific	$287.75M	0.39	$11.40M	$3.72	10.63

32.7% of Kewaunee Scientific shares are held by institutional investors. 0.8% of Syntec Optics shares are held by insiders. Comparatively, 13.3% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syntec Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Kewaunee Scientific beats Syntec Optics on 11 of the 13 factors compared between the two stocks.

How does Kewaunee Scientific compare to Standard BioTools?

Kewaunee Scientific (NASDAQ:KEQU) and Standard BioTools (NASDAQ:LAB) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

Standard BioTools has a net margin of 73.46% compared to Kewaunee Scientific's net margin of 3.85%. Kewaunee Scientific's return on equity of 18.09% beat Standard BioTools' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kewaunee Scientific	3.85%	18.09%	6.71%
Standard BioTools	73.46%	-8.18%	-6.43%

Standard BioTools has a consensus target price of $1.35, indicating a potential upside of 18.42%. Given Standard BioTools' higher possible upside, analysts plainly believe Standard BioTools is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Standard BioTools	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, Kewaunee Scientific had 1 more articles in the media than Standard BioTools. MarketBeat recorded 2 mentions for Kewaunee Scientific and 1 mentions for Standard BioTools. Kewaunee Scientific's average media sentiment score of 0.93 equaled Standard BioTools'average media sentiment score.

Company	Overall Sentiment
Kewaunee Scientific	Positive
Standard BioTools	Positive

32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 53.7% of Standard BioTools shares are held by institutional investors. 13.3% of Kewaunee Scientific shares are held by insiders. Comparatively, 26.8% of Standard BioTools shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Kewaunee Scientific has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market. Comparatively, Standard BioTools has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market.

Kewaunee Scientific has higher revenue and earnings than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kewaunee Scientific	$287.75M	0.39	$11.40M	$3.72	10.63
Standard BioTools	$86.26M	5.16	-$74.90M	$0.20	5.70

Summary

Kewaunee Scientific beats Standard BioTools on 8 of the 14 factors compared between the two stocks.

How does Kewaunee Scientific compare to Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ:NAUT) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

Kewaunee Scientific has a net margin of 3.85% compared to Nautilus Biotechnology's net margin of 0.00%. Kewaunee Scientific's return on equity of 18.09% beat Nautilus Biotechnology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nautilus Biotechnology	N/A	-35.04%	-29.16%
Kewaunee Scientific	3.85%	18.09%	6.71%

In the previous week, Nautilus Biotechnology and Nautilus Biotechnology both had 2 articles in the media. Nautilus Biotechnology's average media sentiment score of 0.94 beat Kewaunee Scientific's score of 0.93 indicating that Nautilus Biotechnology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nautilus Biotechnology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kewaunee Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

50.7% of Nautilus Biotechnology shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 41.1% of Nautilus Biotechnology shares are owned by company insiders. Comparatively, 13.3% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Kewaunee Scientific has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nautilus Biotechnology	N/A	N/A	-$59M	-$0.46	N/A
Kewaunee Scientific	$287.75M	0.39	$11.40M	$3.72	10.63

Nautilus Biotechnology currently has a consensus target price of $4.00, indicating a potential upside of 55.04%. Given Nautilus Biotechnology's higher probable upside, analysts plainly believe Nautilus Biotechnology is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nautilus Biotechnology	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Nautilus Biotechnology has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market.

Summary

Kewaunee Scientific beats Nautilus Biotechnology on 7 of the 13 factors compared between the two stocks.

How does Kewaunee Scientific compare to Prenetics Global?

Kewaunee Scientific (NASDAQ:KEQU) and Prenetics Global (NASDAQ:PRE) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 13.3% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Kewaunee Scientific pays an annual dividend of $0.76 per share and has a dividend yield of 1.9%. Prenetics Global pays an annual dividend of $2.80 per share and has a dividend yield of 13.4%. Kewaunee Scientific pays out 20.4% of its earnings in the form of a dividend. Prenetics Global pays out -69.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Prenetics Global is clearly the better dividend stock, given its higher yield and lower payout ratio.

Kewaunee Scientific has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.24, indicating that its stock price is 76% less volatile than the broader market.

Kewaunee Scientific has a net margin of 3.85% compared to Prenetics Global's net margin of -61.33%. Kewaunee Scientific's return on equity of 18.09% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kewaunee Scientific	3.85%	18.09%	6.71%
Prenetics Global	-61.33%	-19.61%	-15.33%

In the previous week, Kewaunee Scientific and Kewaunee Scientific both had 2 articles in the media. Prenetics Global's average media sentiment score of 0.94 beat Kewaunee Scientific's score of 0.93 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kewaunee Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prenetics Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Kewaunee Scientific has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kewaunee Scientific	$287.75M	0.39	$11.40M	$3.72	10.63
Prenetics Global	$92.39M	3.80	-$37.71M	-$4.02	N/A

Prenetics Global has a consensus price target of $32.33, indicating a potential upside of 55.22%. Given Prenetics Global's stronger consensus rating and higher possible upside, analysts plainly believe Prenetics Global is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Kewaunee Scientific beats Prenetics Global on 10 of the 17 factors compared between the two stocks.

How does Kewaunee Scientific compare to 908 Devices?

908 Devices (NASDAQ:MASS) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

88.1% of 908 Devices shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 28.2% of 908 Devices shares are held by company insiders. Comparatively, 13.3% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

908 Devices presently has a consensus target price of $12.00, suggesting a potential upside of 38.57%. Given 908 Devices' higher possible upside, analysts plainly believe 908 Devices is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
908 Devices	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

908 Devices has higher earnings, but lower revenue than Kewaunee Scientific. 908 Devices is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
908 Devices	$56.20M	5.83	$19.49M	-$1.00	N/A
Kewaunee Scientific	$287.75M	0.39	$11.40M	$3.72	10.63

908 Devices has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market.

In the previous week, 908 Devices had 6 more articles in the media than Kewaunee Scientific. MarketBeat recorded 8 mentions for 908 Devices and 2 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 0.93 beat 908 Devices' score of -0.03 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
908 Devices	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kewaunee Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Kewaunee Scientific has a net margin of 3.85% compared to 908 Devices' net margin of -62.40%. Kewaunee Scientific's return on equity of 18.09% beat 908 Devices' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
908 Devices	-62.40%	-14.03%	-10.40%
Kewaunee Scientific	3.85%	18.09%	6.71%

Summary

Kewaunee Scientific beats 908 Devices on 8 of the 15 factors compared between the two stocks.

Get Kewaunee Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KEQU vs. The Competition

Export

Metric	Kewaunee Scientific	INSTRU Industry	Computer Sector	NASDAQ Exchange
Market Cap	$113.38M	$1.62B	$40.59B	$12.42B
Dividend Yield	N/A	0.34%	3.10%	5.29%
P/E Ratio	10.63	3.54	82.10	24.19
Price / Sales	0.39	1.44	624.91	138.36
Price / Cash	5.55	7.80	51.77	57.88
Price / Book	1.70	3.12	10.09	6.72
Net Income	$11.40M	-$9.28M	$1.06B	$337.19M
7 Day Performance	-1.19%	7.51%	3.81%	0.48%
1 Month Performance	2.62%	10.49%	10.98%	5.07%
1 Year Performance	-4.44%	10.75%	170.16%	34.25%

Kewaunee Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KEQU Kewaunee Scientific	1.674 of 5 stars	$39.56 -2.5%	N/A	+4.5%	$116.29M	$240.47M	9.57	1,239	News Coverage
OPTX Syntec Optics	0.6126 of 5 stars	$11.42 +6.9%	N/A	+732.1%	$430.19M	$28.08M	N/A	3	Gap Up
LAB Standard BioTools	2.1249 of 5 stars	$1.09 +5.8%	$1.35 +23.9%	+10.5%	$402.08M	$85.33M	5.45	620
NAUT Nautilus Biotechnology	3.3254 of 5 stars	$2.43 -4.3%	$4.00 +64.6%	+266.2%	$322.78M	N/A	N/A	130	News Coverage
PRE Prenetics Global	2.8442 of 5 stars	$17.81 +6.2%	$32.33 +81.5%	+127.9%	$282.98M	$92.39M	N/A	1	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KEQU) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kewaunee Scientific (KEQU) Competitors

KEQU vs. OPTX, LAB, NAUT, PRE, and MASS

How does Kewaunee Scientific compare to Syntec Optics?

Summary

How does Kewaunee Scientific compare to Standard BioTools?

Summary

How does Kewaunee Scientific compare to Nautilus Biotechnology?

Summary

How does Kewaunee Scientific compare to Prenetics Global?

Summary

How does Kewaunee Scientific compare to 908 Devices?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KEQU vs. The Competition

Kewaunee Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kewaunee Scientific (KEQU) Competitors

KEQU vs. OPTX, LAB, NAUT, PRE, and MASS

How does Kewaunee Scientific compare to Syntec Optics?

Which has more risk and volatility, OPTX or KEQU?

Is OPTX or KEQU more profitable?

Does the media prefer OPTX or KEQU?

Which has better earnings & valuation, OPTX or KEQU?

Do insiders and institutionals have more ownership in OPTX or KEQU?

Do analysts recommend OPTX or KEQU?

Summary

How does Kewaunee Scientific compare to Standard BioTools?

Is KEQU or LAB more profitable?

Do analysts recommend KEQU or LAB?

Does the media refer more to KEQU or LAB?

Do insiders & institutionals believe in KEQU or LAB?

Which has more risk & volatility, KEQU or LAB?

Which has stronger earnings & valuation, KEQU or LAB?

Summary

How does Kewaunee Scientific compare to Nautilus Biotechnology?

Is NAUT or KEQU more profitable?

Does the media favor NAUT or KEQU?

Do insiders and institutionals believe in NAUT or KEQU?

Which has preferable earnings & valuation, NAUT or KEQU?

Do analysts recommend NAUT or KEQU?

Which has more volatility & risk, NAUT or KEQU?

Summary

How does Kewaunee Scientific compare to Prenetics Global?

Do institutionals and insiders believe in KEQU or PRE?

Is KEQU or PRE a better dividend stock?

Which has more volatility and risk, KEQU or PRE?

Is KEQU or PRE more profitable?

Does the media refer more to KEQU or PRE?

Which has better earnings and valuation, KEQU or PRE?

Do analysts recommend KEQU or PRE?

Summary

How does Kewaunee Scientific compare to 908 Devices?

Do insiders and institutionals hold more shares of MASS or KEQU?

Do analysts prefer MASS or KEQU?

Which has stronger earnings and valuation, MASS or KEQU?

Which has more risk & volatility, MASS or KEQU?

Does the media prefer MASS or KEQU?

Is MASS or KEQU more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KEQU vs. The Competition

Kewaunee Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools